Latest Breaking News On - Fierce innovation awards - Page 2 : comparemela.com

RenovoRx and Imugene Announce Collaboration

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform

New south walesShaun bagaiLeslie chongRenovorx incImugene ltdLife sciences editionDrug delivery technologyImugene announceImugene announce collaborationTrans arterial micro perfusionManaging directorChief executive officerFierce innovation awardsPress releasePress releasesRee press release

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform

 Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platformTAMP enables localized, targeted delivery of CF33 to difficult-to-access tumors, such as pancreatic and liver

New south walesJack perkinsShaun bagaiLeslie chongFacebook imugeneRenovorx incLinkedin imugeneImugene ltdDrug delivery technologyLife sciences editionStrategic communicationsTrans arterial micro perfusionManaging directorChief executive officerFierce innovation awardsOverall survival

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform

New south walesJack perkinsLeslie chongShaun bagaiFacebook imugeneRenovorx incImugene ltdLife sciences editionDrug delivery technologyStrategic communicationsLinkedin imugeneTrans arterial micro perfusionManaging directorChief executive officerFierce innovation awardsOverall survival

Imugene will collaborate with RenovoRx to deliver oncolytic virus through proprietary TAMP platform

Immuno-oncology company Imugene Ltd (ASX:IMU, OTC:IUGNF) has entered into a strategic research collaboration with clinical-stage biopharmaceutical RenovoRx,.

Leslie chongShaun bagaiRenovorx incDrug delivery technologyLife sciences editionImugene ltdSociety of interventional radiologyTrans arterial micro perfusionInterventional radiologyFierce innovation awards

RenovoRx (RNXT) and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using TAMP Platform

RenovoRx (RNXT) and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using TAMP Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shaun bagaiJack perkinsFacebook imugeneLeslie chongRenovorx incImugene ltdDrug delivery technologyLife sciences editionSociety of interventional radiologyStrategic communicationsExchange commissionLinkedin imugeneSecurities exchangeTrans arterial micro perfusionManaging directorChief executive officer